Last edition
News about "Bioconjugation technology"
Asahi Kasei Life Science Acquires License for Novel ADC Technology from The Noguchi Institute
Asahi Kasei Life Science Secures Rights to Novel Antibody Drug Conjugate (ADC) Technology from The Noguchi Institute to Advance Safer and More Efficient Cancer Therapies
Bioconjugation Technology | 28/05/2026 | By News Bureau
NJ Bio, Aji Bio-Pharma Partner to Expand Access to AJICAP Platform
The collaboration between NJ Bio and Bio Pharma aims to accelerate development of next-generation antibody–drug conjugates through advanced site-specific conjugation technology.
Bioconjugation Technology | 01/04/2026 | By News Bureau | 109
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy